We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$853M
AUM Growth
+$41.2M
(+5.1%)
Cap. Flow
-$4.27M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$12.7M |
| 2 |
RPAR Risk Parity ETF
RPAR
|
+$5.28M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$4.15M |
| 4 |
Bank of America
BAC
|
+$4.06M |
| 5 |
NVIDIA
NVDA
|
+$3.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oramed Pharmaceuticals
ORMP
|
+$4.61M |
| 2 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$4.54M |
| 3 |
First Trust Global Tactical Commodity Strategy Fund
FTGC
|
+$4.45M |
| 4 |
iShares US Oil & Gas Exploration & Production ETF
IEO
|
+$4.15M |
| 5 |
AGEN
Agenus
AGEN
|
+$2.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.04% |
| 2 | Technology | 13.3% |
| 3 | Healthcare | 7.37% |
| 4 | Industrials | 3.43% |
| 5 | Consumer Staples | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Revolve Group
RVLV
$1.73B
| $7.08K | ﹤0.01% |
269
| – | – |
|
1677
St. Joe Company
JOE
$3.83B
| $7.07K | ﹤0.01% |
170
+6
| +4% | +$257 |
|
1678
Invesco S&P SmallCap Low Volatility ETF
XSLV
$249M
| $7.07K | ﹤0.01% |
167
| – | – |
|
1679
Orion
OEC
$409M
| $7.07K | ﹤0.01% |
271
| – | – |
|
1680
Tradeweb Markets
TW
$21.6B
| $7.03K | ﹤0.01% |
89
+7
| +9% | +$507 |
|
1681
Sunrun
RUN
$2.46B
| $7.03K | ﹤0.01% |
349
+114
| +49% | +$2.66K |
|
1682
Belden
BDC
$5.19B
| $7.03K | ﹤0.01% |
81
+9
| +13% | +$746 |
|
|
BIG
1683
DELISTED
Big Lots, Inc.
BIG
| $7.03K | ﹤0.01% |
641
+149
| +30% | +$2.25K |
|
|
SRCL
1684
DELISTED
Stericycle Inc
SRCL
| $7.02K | ﹤0.01% |
161
-92
| -36% | -$4.55K |
|
1685
SouthState Bank Corp
SSB
$10.5B
| $6.98K | ﹤0.01% |
98
+51
| +109% | +$3.97K |
|
|
ALX
1686
Alexander's
ALX
$1.41B
| $6.97K | ﹤0.01% |
36
+34
| +1,700% | +$7.36K |
|
|
ARR
1687
Armour Residential REIT
ARR
$2.36B
| $6.97K | ﹤0.01% |
266
+63
| +31% | +$1.78K |
|
|
NTCO
1688
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $6.96K | ﹤0.01% |
1,334
+339
| +34% | +$1.79K |
|
1689
Teva Pharmaceuticals
TEVA
$41.2B
| $6.96K | ﹤0.01% |
786
| – | – |
|
|
KW
1690
DELISTED
Kennedy-Wilson Holdings
KW
| $6.95K | ﹤0.01% |
419
+106
| +34% | +$1.8K |
|
1691
Acadia Healthcare
ACHC
$2.94B
| $6.94K | ﹤0.01% |
96
+49
| +104% | +$3.82K |
|
1692
KeyCorp
KEY
$24.4B
| $6.94K | ﹤0.01% |
554
-1,396
| -72% | -$23.6K |
|
1693
Televisa
TV
$1.49B
| $6.93K | ﹤0.01% |
+1,311
| New | +$7.03K |
|
1694
Mercer International
MERC
$39.8M
| $6.93K | ﹤0.01% |
+709
| New | +$8K |
|
1695
Cactus
WHD
$5.44B
| $6.93K | ﹤0.01% |
168
-97
| -37% | -$4.68K |
|
1696
Federal Agricultural Mortgage
AGM
$2.56B
| $6.93K | ﹤0.01% |
52
-2
| -4% | -$263 |
|
1697
NMI Holdings
NMIH
$3.36B
| $6.9K | ﹤0.01% |
309
-26
| -8% | -$583 |
|
1698
TFS Financial
TFSL
$4.93B
| $6.9K | ﹤0.01% |
546
+418
| +327% | +$5.84K |
|
1699
MillerKnoll
MLKN
$1.67B
| $6.87K | ﹤0.01% |
336
+176
| +110% | +$3.96K |
|
1700
Cleveland-Cliffs
CLF
$6.99B
| $6.86K | ﹤0.01% |
374
+60
| +19% | +$1.19K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.
- Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
- Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
- Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
- Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
- Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
- Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.
Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.